entity

TDP-43 phase separation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TDP-43 phase separation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
3Hypotheses
2Analyses
1Outgoing
1Incoming
0Experiments
3Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
Splicing regulationregulatesprocess0.90

Incoming (1)

SourceRelationTypeStr
DPR_proteinsdisruptsprotein0.90

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
RNA-binding protein condensate maturation from reversible ph 0.626 neurodegeneration Biophysical Determinants Shifting FUS/TD
Cell-state stratification is required to resolve Biophysical 0.612 neurodegeneration Biophysical Determinants Shifting FUS/TD
Perturbation-first validation should precede therapeutic cla 0.608 neurodegeneration Biophysical Determinants Shifting FUS/TD

Mentioning Analyses (2)

Scientific analyses that reference this entity

What are the specific design principles for small molecules that can selectively

medicinal chemistry | 2026-04-10 | 0 hypotheses

TDP-43 phase separation therapeutics for ALS-FTD

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.738

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

The debate identified that TDP-43 undergoes both normal and pathological phase s

closed · Rounds: 4 · Score: 0.43 · 2026-04-21

TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small

closed · Rounds: 6 · Score: 0.84 · 2026-04-12

TDP-43 phase separation therapeutics for ALS-FTD

closed · Rounds: 4 · Score: 0.95 · 2026-04-11

Related Research

Hypotheses and analyses mentioning TDP-43 phase separation in their description or question text

No additional research found